TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Takeda Pharma AB
Closing information (x1000 SEK)
Closing information | 2024/03 | 2023/03 | 2022/03 |
Turnover |
2,281,670
|
2,057,423
|
1,767,263 |
Financial expenses |
3,311
|
15,887
|
4,425 |
Earnings before taxes |
74,469
|
62,404
|
60,479 |
EBITDA |
78,702
|
70,518
|
63,611 |
Total assets |
887,601
|
777,913
|
714,804 |
Current assets |
882,612
|
772,060
|
704,115 |
Current liabilities |
579,808
|
525,503
|
507,554 |
Equity capital |
305,259
|
249,651
|
203,716 |
- share capital |
2,000
![]() |
2,000
![]() |
2,000 |
Employees (average) |
99
|
101
![]() |
101 |
Financial ratios
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Solvency |
34.4%
|
32.1%
|
28.5% |
Turnover per employee |
23,047
|
20,371
|
17,498 |
Profit as a percentage of turnover |
3.3%
|
3.0%
|
3.4% |
Return on assets (ROA) |
8.8%
|
10.1%
|
9.1% |
Current ratio |
152.2%
|
146.9%
|
138.7% |
Return on equity (ROE) |
24.4%
|
25.0%
|
29.7% |
Change turnover |
224,247
|
290,160
|
-295,546 |
Change turnover % |
11%
|
16%
|
-14% |
Chg. No. of employees |
-2
|
0
|
-11 |
Chg. No. of employees % |
-2%
|
0%
|
-10% |
Total value of public sale
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.